Talis Biomedical Corp
TLIS
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.18M
Close$
Share Statistics
| Market cap | $5.18 Million |
|---|---|
| Enterprise Value | $-35,890,190.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-34.12 |
| Beta | 1.32 |
| Outstanding Shares | 1,822,422 |
Return
| Return on Equity | -104.94% |
|---|---|
| Return on Assets | -70.19% |
| Return on Invested Capital | -76.27% |
Valuation & Multiples
| P/E Ratio | -0.08 |
|---|---|
| PEG | 0.2 |
| Price to Sales | - |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | -119.63 |
| Enterprise Value to EBIT | 0.73 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.52 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Talis Biomedical Corp
135 employeesTalis is dedicated to transforming diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, low cost and rapid molecular testing for infectious diseases at the point-of-care, beginnin...